tiprankstipranks
Trending News
More News >
Amneal Pharma (AMRX)
:AMRX
US Market

Amneal Pharmaceuticals (AMRX) Income Statement

Compare
574 Followers

Amneal Pharmaceuticals Income Statement

Last quarter (Q3 2025), Amneal Pharmaceuticals's total revenue was $784.51M, an increase of 11.68% from the same quarter last year. In Q3, Amneal Pharmaceuticals's net income was $2.37M. See Amneal Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.79B$ 2.39B$ 2.21B$ 2.09B$ 1.99B
Gross Profit
$ 1.02B$ 863.87M$ 791.46M$ 768.97M$ 628.39M
Operating Expenses
$ 771.11M$ 659.50M$ 886.39M$ 616.26M$ 537.24M
Depreciation and Amortization
$ 236.19M$ 229.40M$ 240.18M$ 233.41M$ 235.39M
EBITDA
$ 439.77M$ 500.78M$ 440.21M$ 401.10M$ 345.61M
Operating Income
$ 249.33M$ 204.37M$ -94.93M$ 152.72M$ 91.16M
Other Income/Expenses
$ -304.34M$ -244.64M$ -153.20M$ -121.35M$ -126.94M
Pretax Income
$ -55.01M$ -40.27M$ -248.13M$ 31.37M$ -35.78M
Net Income
$ -116.89M$ -83.99M$ -129.99M$ 10.62M$ 91.06M
Per Share Metrics
Basic EPS
$ -0.38$ -0.48$ -0.86$ 0.07$ 0.62
Diluted EPS
$ -0.38$ -0.48$ -0.86$ 0.07$ 0.61
Weighted Average Shares Outstanding
308.98M 174.99M 150.94M 148.92M 149.28M
Weighted Average Shares Outstanding (Diluted)
308.98M 176.14M 150.94M 151.82M 148.91M
Currency in USD

Amneal Pharmaceuticals Earnings and Revenue History